Axithra
PrivateLast Round
Series A
Apr 24, 2026
Total Funding Raised
$10.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Axithra operates in Healthcare & Life Sciences and is based in Belgium. Its latest recorded funding round was a Seed round in September 2023.
Axithra is a medical diagnostics company developing a therapeutic drug monitoring platform based on optical and photonics technology to measure drug concentrations in blood.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Precision Medicine, Semiconductors, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axithra Comparables
Compare Axithra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlmeMed | 85% | |
| Roche Holding | 66% | |
| Saladax Biomedical, Inc. | 66% |
For institutional investors. Book with your work email.
Axithra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 24, 2026 | ||||
| Seed | Sep 5, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axithra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Seed |
| White Fund | Seed |
| imec.xpand | Seed |
| Kurma Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 8, 42% of headcount.
- Apr 24, 2026
Completed a Series A funding round.
For institutional investors. Book with your work email.
Axithra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axithra's valuation, stock price, and market status.
Is Axithra a public or private company?
Axithra is a private company.
What is the current stock price of Axithra?
Axithra is a private company, so its shares have no public market price. Caplight tracks Axithra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axithra worth (valuation)?
Valuation information for Axithra is not publicly available.
Can I buy Axithra stock?
Axithra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axithra's last funding round?
Axithra's most recent funding round was Series A on April 24, 2026.
Who are the main investors in Axithra?
Key investors in Axithra include imec.xpand, Kurma Partners.
Will Axithra IPO soon?
No public IPO plans have been announced for Axithra.
How can I track Axithra secondary market activity?
Caplight tracks bids, offers, and trades in Axithra's shares on secondary markets.